Company Info
Year Established2018
Contacts
Andrew Pearlman, Ph.D.Co-Founder & President
Hermann Russ, M.D. Ph.D.
Co-Founder & CSO
Alexander Gebauer, M.D., Ph.D.
Co-Founer & Executive Chair
Phyllis K. Bellin, M.B.A.
Co-Founder & CFO
Company Description
Galimedix is a Phase 2 clinical-stage company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases.
